Tatiana Vladimirovna Sams, MD
Endocrinology · Torrance
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Healthcare Partners Affiliates Medical Group · 775 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sams’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A130098 · Current
Licensed to practise in California · since 2014 · expires 2028-03-31 · Novosibirsk Medical Institute.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$18,210
Medicare paid this office $18,210 for 78 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 28 | $6,805 | $93 |
| Short return visit (20+ min) | 39 | $4,146 | $71 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $3,642 | $104 |
| Short return visit | 18 | $1,098 | $37 |
Who their Medicare patients are
78 Original Medicare patients in 2024. Average age 72 · Women 65% · Health risk score 1.23. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 73% · Diabetes 55% · Chronic kidney disease 36% · Coronary heart disease 23% · Depression 17% · Cancer 15%.
The office billed $72,358, Medicare allowed $26,176 and paid $18,210; for 362 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 78 | 362 | 72 | 1.23 | $72,358 | $18,210 |
| 2023 | 108 | 243 | 73 | 1.28 | $37,290 | $17,653 |
| 2022 | 45 | 83 | 73 | 1.59 | $11,452 | $6,877 |
| 2021 | 92 | 141 | 71 | 1.44 | $20,692 | $4,383 |
| 2019 | 78 | 280 | 69 | 4.24 | $104,344 | $23,249 |
| 2018 | 47 | 147 | 71 | 3.24 | $58,376 | $14,047 |
| 2017 | 107 | 1,107 | 72 | 1.91 | $57,352 | $19,975 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 81 | $7,563 | $64 |
| Return visit (30+ min) | 32 | $5,851 | $101 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,058 | $76 |
| Short return visit | 13 | $696 | $37 |
2022: 2 services
| Short return visit (20+ min) | 28 | $2,827 | $74 |
| New patient visit (30+ min) | 12 | $1,196 | $100 |
2021: 3 services
| Short return visit (20+ min) | 42 | $1,748 | $41 |
| Short return visit | 22 | $559 | $24 |
| Hemoglobin a1c level | 32 | $296 | $9 |
2019: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $9,489 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,485 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $4,281 | $62 |
| Return visit (30+ min) | 18 | $1,683 | $67 |
| Return visit (30+ min) | 16 | $1,422 | $62 |
| Short return visit (20+ min) | 11 | $567 | $44 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $6,519 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,275 | $114 |
| Return visit (30+ min) | 16 | $2,213 | $92 |
| New patient visit (45+ min) | 15 | $2,094 | $140 |
2017: 4 services
| Injection, denosumab, 1 mg | 16 | $10,716 | None |
| Return visit (30+ min) | 59 | $5,094 | $70 |
| Dxa bone density measurement of hip, pelvis, spine | 34 | $1,584 | $47 |
| Injection of drug or substance under skin or into muscle | 16 | $280 | $18 |
Medicaid work
$1,865 in 2021
Medicaid paid $1,865 for 71 billed services this clinician did in 2021, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 45 | $1,107 |
| Short return visit (20+ min) | 26 | $758 |
| 2021 | 71 | 2 | 25 | $1,865 |
| 2020 | 159 | 4 | 21 | $2,505 |
| 2019 | 145 | 3 | 25 | $532 |
| 2018 | 24 | 1 | 12 | $1,211 |
See the largest Medicaid services in earlier years
2020
| New patient visit (30+ min) | 60 | $1,791 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 14 | $298 |
| Short return visit (20+ min) | 14 | $264 |
| Discharge medications reconciled with the current medication list in outpatient medical record (COA) (GER) | 71 | $152 |
2019
| New patient visit (30+ min) | 19 | $289 |
| Return visit (30+ min) | 113 | $176 |
| Short return visit (20+ min) | 13 | $67 |
2018
| Return visit (30+ min) | 24 | $1,211 |
Drugs they prescribed that Part D paid
$1,605,837
Pharmacies billed $1,605,837 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,363) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
887 generic and 1,248 brand-name prescriptions · $1,605,837 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 180 | $298,568 | $1,659 |
| Jardiance | 96 | $115,016 | $1,198 |
| Rybelsus | 74 | $103,096 | $1,393 |
| Trulicity | 56 | $86,532 | $1,545 |
| Ozempic | 39 | $81,990 | $2,102 |
See all 46 drugs
| Mounjaro | 180 | $298,568 | $1,659 |
| Jardiance | 96 | $115,016 | $1,198 |
| Rybelsus | 74 | $103,096 | $1,393 |
| Trulicity | 56 | $86,532 | $1,545 |
| Ozempic | 39 | $81,990 | $2,102 |
| Januvia | 51 | $58,954 | $1,156 |
| Farxiga | 45 | $55,418 | $1,232 |
| Tymlos | 14 | $38,181 | $2,727 |
| Toujeo Solostar | 43 | $34,320 | $798 |
| Tresiba Flextouch U-100 | 53 | $31,993 | $604 |
| Humalog Kwikpen U-200 | 21 | $27,778 | $1,323 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | 19 | $26,857 | $1,414 |
| Tresiba Flextouch U-200 | 17 | $18,620 | $1,095 |
| Humalog Kwikpen U-100 | 75 | $17,358 | $231 |
| Vascepa | 29 | $16,020 | $552 |
| Humalog | 43 | $12,058 | $280 |
| Lantus Solostar | 103 | $11,837 | $115 |
| Icosapent Ethyl | 31 | $9,331 | $301 |
| Praluent | 14 | $8,797 | $628 |
| Nano 2nd Gen Pen Needle | 83 | $8,272 | $100 |
| Novolog Flexpen | 25 | $5,204 | $208 |
| Levothyroxine | 217 | $3,727 | $17 |
| Lantus | 21 | $3,559 | $169 |
| Synthroid | 39 | $2,972 | $76 |
| Ultra-Fine Mini Pen Needle | 22 | $2,833 | $129 |
| Droplet Pen Needle | 18 | $2,069 | $115 |
| Levoxyl | 20 | $1,884 | $94 |
| Repaglinide | 36 | $1,657 | $46 |
| Ultra-Fine Nano Pen Needle | 13 | $1,387 | $107 |
| Insulin | 11 | $1,292 | $117 |
| Metformin Hcl Er | 69 | $1,222 | $18 |
| Hydrocortisone | 22 | $1,132 | $51 |
| Glimepiride | 68 | $1,082 | $16 |
| Rosuvastatin | 68 | $1,011 | $15 |
| Testosterone | 14 | $970 | $69 |
| Liothyronine | 26 | $954 | $37 |
| Ezetimibe | 32 | $893 | $28 |
| Methimazole | 67 | $803 | $12 |
| Metformin | 64 | $786 | $12 |
| Calcitriol | 20 | $609 | $30 |
| Insulin Lispro | 13 | $540 | $42 |
| Testosterone Cypionate | 11 | $525 | $48 |
| Pioglitazone | 39 | $360 | $9 |
| Atorvastatin | 35 | $343 | $10 |
| Glipizide Er | 12 | $204 | $17 |
| Glipizide | 15 | $144 | $10 |
Year by year
| 2024 | 2,363 | 360 | 0% (0) | 53% | $1,605,837 |
| 2023 | 2,718 | 358 | 0% (0) | 51% | $1,512,514 |
| 2022 | 883 | 231 | 0% (0) | 50% | $356,773 |
| 2021 | 630 | 117 | 0% (0) | 53% | $250,043 |
| 2020 | 121 | 32 | 0% (0) | 34% | $16,602 |
| 2019 | 571 | 58 | None | 56% | $198,832 |
| 2018 | 341 | 60 | 0% (0) | 58% | $106,201 |
| 2017 | 1,068 | 203 | 0% (0) | 61% | $428,535 |
| 2016 | 617 | 114 | 0% (0) | 40% | $122,405 |
| 2015 | 521 | 56 | None | 39% | $72,312 |
| 2014 | 234 | 58 | None | None | $24,645 |
| 2013 | 147 | 25 | None | 18% | $4,378 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Trulicity | 106 | $169,810 | $1,602 |
| Jardiance | 174 | $163,196 | $938 |
| Mounjaro | 66 | $120,210 | $1,821 |
| Farxiga | 130 | $118,905 | $915 |
| Ozempic | 63 | $98,692 | $1,567 |
| Januvia | 91 | $66,133 | $727 |
| Humalog Kwikpen U-100 | 72 | $62,504 | $868 |
| Lantus Solostar | 98 | $60,990 | $622 |
| Humalog | 49 | $53,066 | $1,083 |
| Toujeo Solostar | 54 | $44,962 | $833 |
| Novolog Flexpen | 35 | $43,051 | $1,230 |
| Tymlos | 12 | $33,700 | $2,808 |
| Rybelsus | 28 | $33,328 | $1,190 |
| Tresiba Flextouch U-200 | 21 | $26,451 | $1,260 |
| Toujeo Max Solostar | 20 | $22,127 | $1,106 |
| Humalog Kwikpen U-200 | 13 | $21,527 | $1,656 |
| Levemir Flexpen | 25 | $19,734 | $789 |
| Icosapent Ethyl | 51 | $18,486 | $362 |
| Tresiba Flextouch U-100 | 27 | $18,306 | $678 |
| Tradjenta | 12 | $17,931 | $1,494 |
| Lantus | 25 | $17,603 | $704 |
| Omnipod 5 G6 Pods (Gen 5) | 17 | $16,463 | $968 |
| Nano 2nd Gen Pen Needle | 98 | $8,450 | $86 |
| Levothyroxine | 223 | $5,911 | $27 |
| Rosuvastatin | 103 | $5,888 | $57 |
| Basaglar Kwikpen U-100 | 14 | $5,095 | $364 |
| Ultra-Fine Mini Pen Needle | 44 | $5,026 | $114 |
| Repaglinide | 34 | $4,663 | $137 |
| Ezetimibe | 54 | $3,159 | $59 |
| Cinacalcet | 18 | $2,935 | $163 |
| Synthroid | 30 | $2,822 | $94 |
| Droplet Pen Needle | 33 | $2,348 | $71 |
| Ultra-Fine Short Pen Needle | 12 | $2,305 | $192 |
| Metformin Hcl Er | 66 | $1,978 | $30 |
| Testosterone | 11 | $1,882 | $171 |
| Insulin | 18 | $1,834 | $102 |
| Liothyronine | 36 | $1,678 | $47 |
| Metformin | 82 | $1,482 | $18 |
| Ultra-Fine Nano Pen Needle | 18 | $1,455 | $81 |
| Atorvastatin | 63 | $1,393 | $22 |
| Glimepiride | 52 | $1,287 | $25 |
| Methimazole | 75 | $1,133 | $15 |
| Veo Insulin | 11 | $1,101 | $100 |
| Hydrocortisone | 11 | $662 | $60 |
| Calcitriol | 13 | $599 | $46 |
| Glipizide | 32 | $547 | $17 |
| Pioglitazone | 24 | $545 | $23 |
| Lovastatin | 12 | $183 | $15 |
| Alendronate | 13 | $142 | $11 |
| Levoxyl | 15 | $141 | $9 |
| Simvastatin | 11 | $107 | $10 |
2022: 21 drugs
| Trulicity | 53 | $60,455 | $1,141 |
| Farxiga | 61 | $48,097 | $788 |
| Jardiance | 63 | $47,083 | $747 |
| Lantus Solostar | 47 | $29,332 | $624 |
| Januvia | 27 | $25,877 | $958 |
| Humalog Kwikpen U-100 | 24 | $24,308 | $1,013 |
| Novolog Flexpen | 16 | $14,402 | $900 |
| Toujeo Solostar | 19 | $11,370 | $598 |
| Levothyroxine | 74 | $1,607 | $22 |
| Nano 2nd Gen Pen Needle | 21 | $1,482 | $71 |
| Rosuvastatin | 36 | $1,478 | $41 |
| Synthroid | 19 | $1,349 | $71 |
| Ezetimibe | 19 | $1,207 | $64 |
| Ultra-Fine Mini Pen Needle | 12 | $1,057 | $88 |
| Liothyronine | 12 | $995 | $83 |
| Ultra-Fine Micro Pen Needle | 12 | $888 | $74 |
| Atorvastatin | 47 | $791 | $17 |
| Metformin | 47 | $613 | $13 |
| Methimazole | 29 | $513 | $18 |
| Glimepiride | 26 | $470 | $18 |
| Metformin Hcl Er | 15 | $452 | $30 |
2021: 18 drugs
| Trulicity | 57 | $52,197 | $916 |
| Jardiance | 68 | $46,619 | $686 |
| Lantus Solostar | 25 | $14,409 | $576 |
| Humalog Kwikpen U-100 | 15 | $8,692 | $579 |
| Fiasp Flextouch | 15 | $8,028 | $535 |
| Tirosint | 12 | $2,290 | $191 |
| Levothyroxine | 50 | $1,028 | $21 |
| Synthroid | 19 | $997 | $52 |
| Methimazole | 44 | $684 | $16 |
| Hydrocortisone | 11 | $604 | $55 |
| Nano 2nd Gen Pen Needle | 11 | $543 | $49 |
| Glimepiride | 23 | $206 | $9 |
| Ezetimibe | 12 | $205 | $17 |
| Metformin | 37 | $201 | $5 |
| Atorvastatin | 14 | $195 | $14 |
| Metformin Hcl Er | 12 | $162 | $14 |
| Alendronate | 16 | $126 | $8 |
| Losartan | 11 | $90 | $8 |
2020: 4 drugs
| Jardiance | 14 | $7,373 | $527 |
| Levothyroxine | 14 | $180 | $13 |
| Atorvastatin | 17 | $87 | $5 |
| Metformin | 13 | $69 | $5 |
2019: 15 drugs
| Trulicity | 99 | $81,425 | $822 |
| Tresiba Flextouch U-200 | 36 | $17,303 | $481 |
| Humalog Kwikpen U-100 | 20 | $16,167 | $808 |
| Jardiance | 27 | $13,028 | $483 |
| Januvia | 19 | $12,422 | $654 |
| Ozempic | 13 | $11,714 | $901 |
| Novolog Flexpen | 13 | $11,522 | $886 |
| Tresiba Flextouch U-100 | 15 | $3,906 | $260 |
| Alcohol Pads | 14 | $963 | $69 |
| Ultra-Fine Nano Pen Needle | 16 | $793 | $50 |
| Levothyroxine | 34 | $603 | $18 |
| Atorvastatin | 39 | $525 | $13 |
| Metformin | 32 | $194 | $6 |
| Glimepiride | 25 | $116 | $5 |
| Glipizide | 25 | $84 | $3 |
2018: 12 drugs
| Trulicity | 36 | $27,118 | $753 |
| Januvia | 26 | $14,683 | $565 |
| Tresiba Flextouch U-200 | 15 | $9,632 | $642 |
| Humalog Kwikpen U-100 | 18 | $8,397 | $466 |
| Novolog Flexpen | 11 | $6,346 | $577 |
| Lantus Solostar | 12 | $3,651 | $304 |
| Ultra-Fine Original Pen Needle | 12 | $743 | $62 |
| Levothyroxine | 25 | $308 | $12 |
| Atorvastatin | 20 | $201 | $10 |
| Metformin | 26 | $160 | $6 |
| Lovastatin | 12 | $55 | $5 |
| Glipizide | 13 | $30 | $2 |
2017: 28 drugs
| Humalog Kwikpen U-100 | 48 | $48,504 | $1,010 |
| Humalog | 69 | $47,272 | $685 |
| Trulicity | 51 | $44,384 | $870 |
| Novolog | 19 | $38,794 | $2,042 |
| Tradjenta | 49 | $30,191 | $616 |
| Januvia | 49 | $29,270 | $597 |
| Lantus Solostar | 47 | $22,721 | $483 |
| Bydureon | 28 | $19,159 | $684 |
| Invokana | 35 | $18,107 | $517 |
| Lantus | 33 | $17,372 | $526 |
| Prolia | 16 | $17,103 | $1,069 |
| Toujeo Solostar | 30 | $13,151 | $438 |
| Humalog Mix 75-25 | 14 | $10,932 | $781 |
| Novolog Flexpen | 11 | $9,347 | $850 |
| Humalog Mix 75-25 Kwikpen | 11 | $8,678 | $789 |
| Levothyroxine | 117 | $2,844 | $24 |
| Ultra-Fine Nano Pen Needle | 28 | $1,318 | $47 |
| Metformin | 83 | $715 | $9 |
| Hydrocortisone | 12 | $578 | $48 |
| Atorvastatin | 32 | $475 | $15 |
| Insulin | 11 | $324 | $29 |
| Fenofibrate | 12 | $277 | $23 |
| Glipizide | 26 | $220 | $8 |
| Losartan | 13 | $178 | $14 |
| Propranolol | 12 | $168 | $14 |
| Glimepiride | 15 | $126 | $8 |
| Methimazole | 11 | $108 | $10 |
| Simvastatin | 14 | $52 | $4 |
2016: 19 drugs
| Humalog Kwikpen U-100 | 22 | $20,338 | $924 |
| Januvia | 34 | $14,710 | $433 |
| Lantus Solostar | 12 | $8,577 | $715 |
| Novolog | 14 | $7,849 | $561 |
| Lantus | 16 | $7,373 | $461 |
| Omega-3 Acid Ethyl Esters | 11 | $1,434 | $130 |
| Levothyroxine | 64 | $1,309 | $20 |
| Bd Ultra-Fine Pen Needle | 25 | $1,288 | $52 |
| Atorvastatin | 52 | $770 | $15 |
| Glimepiride | 41 | $637 | $16 |
| Fenofibrate | 11 | $583 | $53 |
| Hydrocortisone | 21 | $492 | $23 |
| Metformin | 47 | $343 | $7 |
| Amlodipine Besylate | 15 | $114 | $8 |
| Methimazole | 11 | $113 | $10 |
| Glipizide | 26 | $108 | $4 |
| Losartan | 11 | $93 | $8 |
| Metoprolol | 11 | $72 | $7 |
| Simvastatin | 11 | $42 | $4 |
2015: 17 drugs
| Humalog Kwikpen U-100 | 13 | $9,578 | $737 |
| Januvia | 13 | $6,354 | $489 |
| Lantus | 16 | $5,753 | $360 |
| Novolog | 15 | $5,530 | $369 |
| Lantus Solostar | 11 | $4,998 | $454 |
| Humalog | 12 | $3,731 | $311 |
| Atorvastatin | 49 | $1,197 | $24 |
| Bd Ultra-Fine Pen Needle | 20 | $1,000 | $50 |
| Levothyroxine | 46 | $903 | $20 |
| Hydrocortisone | 12 | $510 | $42 |
| Insulin | 12 | $344 | $29 |
| Losartan | 11 | $314 | $29 |
| Pravastatin | 14 | $232 | $17 |
| Glimepiride | 41 | $176 | $4 |
| Amlodipine Besylate | 28 | $147 | $5 |
| Metformin | 21 | $131 | $6 |
| Glipizide | 16 | $41 | $3 |
2014: 5 drugs
| Humalog | 11 | $5,020 | $456 |
| Lantus | 11 | $3,767 | $342 |
| Levothyroxine | 17 | $228 | $13 |
| Atorvastatin | 18 | $160 | $9 |
| Metformin | 20 | $112 | $6 |
2013: 3 drugs
| Simvastatin | 14 | $97 | $7 |
| Metformin | 14 | $97 | $7 |
| Lisinopril | 11 | $57 | $5 |
Money from drug and device companies
$1,122 in 2025
| 2025 | 2 | 11 | None | $1,122 |
| 2024 | 5 | 19 | None | $1,239 |
| 2023 | 2 | 7 | None | $490 |
| 2021 | 2 | 2 | None | $29 |
| 2020 | 1 | 1 | None | $116 |
| 2019 | 6 | 17 | None | $583 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Dexcom | Dexcom G6 Transmitter | $895 | 9 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $228 | 2 payments
|
See all 11 published payments
| Abbott Laboratories | Meals · 2025-12-14 | Freestyle Libre 3 | $118 |
| Dexcom | Meals · 2025-12-12 | Dexcom G6 Transmitter | $143 |
| Dexcom | Meals · 2025-10-23 | Dexcom G6 Transmitter | $46 |
| Abbott Laboratories | Meals · 2025-09-19 | Freestyle Libre 3 | $110 |
| Dexcom | Meals · 2025-09-06 | Dexcom G6 Transmitter | $57 |
| Dexcom | Meals · 2025-09-05 | Dexcom G6 Transmitter | $146 |
| Dexcom | Meals · 2025-07-24 | Dexcom G6 Transmitter | $116 |
| Dexcom | Meals · 2025-04-29 | Dexcom G6 Transmitter | $138 |
| Dexcom | Meals · 2025-02-02 | Dexcom G6 Transmitter | $116 |
| Dexcom | Meals · 2025-01-17 | Dexcom G6 Transmitter | $110 |
| Dexcom | Meals · 2025-01-12 | Dexcom G6 Transmitter | $23 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $1,239
| Dexcom | Dexcom G6 Transmitter | $910 | 13 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $155 | 3 payments
|
| Lilly USA | Mounjaro | $121 | 1 payment
|
| Mannkind | Afrezza | $31 | 1 payment
|
| Amgen | Tepezza | $21 | 1 payment
|
2023: $490
| Horizon Therapeutics plc | Tepezza | $271 | 4 payments
|
| Dexcom | Dexcom G6 Transmitter | $220 | 3 payments
|
2021: $29
| Lilly USA | Trulicity | $15 | 1 payment
|
| Insulet | Omnipod | $14 | 1 payment
|
2020: $116
| AstraZeneca Pharmaceuticals LP | Farxiga | $116 | 1 payment
|
2019: $583
| Lilly USA | Jardiance | $247 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $213 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $42 | 2 payments
|
| Amgen | Evenity | $37 | 1 payment
|
| Medtronic Vascular | Claria Mri | $23 | 1 payment
|
| Abbott Laboratories | Freestyle Libre | $21 | 1 payment
|
Professional record
- NPI
- 1174815427
- Licence
- CA A130098California A130098: Current · expires 2028-03-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- Po Box 35380, Las Vegas, NV, 89133
- NPI first listed
- 2011-05-04
- NPI last updated
- 2026-01-08
- NPI record certified
- 2026-01-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 50 E Hamilton Ave Ste 280, Campbell, CA, 95008 · 5800 Hollis St Fl 4, Emeryville, CA, 94608 · 1866 N Orange Grove Ave, Pomona, CA, 91767